Africa: Momentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To Action: [IAS] New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck's once-monthly oral pill MK-8527 advances to Phase 3… http://newsfeed.facilit8.network/TLwRPZ #HIVAwareness #HIVPrevention #LongActingSolutions #HealthcareInnovation #IAS2025